Treatment of mastocytosis: pharmacologic basis and current concepts
- 22 May 2001
- journal article
- review article
- Published by Elsevier BV in Leukemia Research
- Vol. 25 (7), 583-594
- https://doi.org/10.1016/s0145-2126(01)00039-x
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Generic Signals and Specific OutcomesCell, 1999
- Treatment of Three Patients with Systemic Mastocytosis with Interferon Alpha-2bLeukemia & Lymphoma, 1996
- Human Basophil/Mast Cell ReleasabilityAnesthesiology, 1992
- Inhibition of histamine release from human FcεRI+ cells by nimesulideInflammation Research, 1992
- Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretionLife Sciences, 1989
- Intractable ascites in systemic mastocytosis treated by portal diversionDigestive Diseases and Sciences, 1987
- Treatment of urticaria pigmentosa with corticosteroidsArchives of Dermatology, 1985
- Evidence for an adenosine A2/Ra receptor on human basophilsLife Sciences, 1985
- Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycateBritish Journal of Dermatology, 1981
- Oral Disodium Cromoglycate in the Treatment of Systemic MastocytosisNew England Journal of Medicine, 1979